Difference between revisions of "Spebrutinib (CC-292)"
Jump to navigation
Jump to search
(Created page with "=Mechanism of action= Bruton's tyrosine kinase (BTK) inhibitor Category:Investigational Category:Kinase inhibitors Category:BTK inhibitors") |
m |
||
| Line 2: | Line 2: | ||
Bruton's tyrosine kinase (BTK) inhibitor | Bruton's tyrosine kinase (BTK) inhibitor | ||
| − | [[Category: | + | [[Category:Drug index]] |
| + | [[Category:Chemotherapy]] | ||
[[Category:Kinase inhibitors]] | [[Category:Kinase inhibitors]] | ||
[[Category:BTK inhibitors]] | [[Category:BTK inhibitors]] | ||
| + | |||
| + | [[Category:Investigational]] | ||
Revision as of 03:32, 16 November 2014
Mechanism of action
Bruton's tyrosine kinase (BTK) inhibitor